Skip to main content
Log in

Comparing the efficacy of catheter ablation strategies for persistent atrial fibrillation: a Bayesian analysis of randomized controlled trials

  • Reviews
  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Background

Catheter ablation has been recommended as the first-line treatment option for selected patients with atrial fibrillation (AF). However, a widely accepted ablation strategy for persistent AF (perAF) has not yet been established. The benefits of ablation strategies are not conclusive for perAF. There is an urgent need to systematically analyze the results of previous studies and rank these treatment strategies to guide clinical practice.

Methods

Randomized controlled trials (RCTs) on ablation for perAF were included. The primary outcome was recurrence of atrial tachyarrhythmia (AT) after a single ablation procedure. A Bayesian random-effects network meta-analysis model was fitted.

Results

Twenty-three studies were included in the analysis. A total of 3394 patients and 22 ablation strategies were found in the involved studies. The ablation strategy of pulmonary vein isolation (PVI) + electrical box isolation of the left atrial posterior wall (PBOX) + non-PV trigger ablation (NPV) showed the best treatment effect in terms of the primary outcome. The individualized ablation strategies of mapping and ablation combined with PVI, such as PVI + rotors, PVI + dispersion areas, and PVI + low voltage zone (LVZ) also showed a better ablation effect in perAF.

Conclusions

PVI ablation is a widely used strategy in perAF and is recognized as a cornerstone procedure for perAF. The PVI + PBOX + NPV strategy showed the highest rank in our analysis. Mapping and ablation strategies that could provide individualized substrate modification also showed a better rank in our analysis and are believed to be a promising direction for the treatment of perAF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Ouyang F, Bansch D, Ernst S, Schaumann A, Hachiya H, Chen M, Chun J, Falk P, Khanedani A, Antz M, Kuck KH. Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation. Circulation. 2004;110:2090–6.

    Article  PubMed  Google Scholar 

  2. Nishizaki K, Itoh T, Kimura M, Tsushima Y, Shoji Y, Kinjo T, Ishida Y, Sasaki K, Horiuchi D, Sasaki S, Tomita H, Okumura K. Safety and efficacy of contemporary catheter ablation for atrial fibrillation patients with a history of cardioembolic stroke in the era of direct oral anticoagulants. J Cardiol. 2017;70:86–91.

    Article  PubMed  Google Scholar 

  3. Yoshiga Y, Shimizu A, Ueyama T, Ono M, Fukuda M, Fumimoto T, Ishiguchi H, Omuro T, Kobayashi S, Yano M. Strict sequential catheter ablation strategy targeting the pulmonary veins and superior vena cava for persistent atrial fibrillation. J Cardiol. 2018;72:128–34.

    Article  PubMed  Google Scholar 

  4. Kistler PM, Chieng D. Persistent atrial fibrillation in the setting of pulmonary vein isolation-Where to next? J Cardiovasc Electrophysiol. 2020;31:1857–60.

    Article  PubMed  Google Scholar 

  5. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL and Group ESCSD. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373–498.

    Google Scholar 

  6. Bisbal MdF, Ph MM, DL. New insights on ablation of persistent atrial fibrillation: evidence from the SARA trial. J Atr Fibrillation. 2014;7:1114.

    PubMed Central  Google Scholar 

  7. Verma A, Macle L. Persistent atrial fibrillation ablation: where do we go from here? Can J Cardiol. 2018;34:1471–81.

    Article  PubMed  Google Scholar 

  8. Verma A, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan R, Macle L, Morillo CA, Haverkamp W, Weerasooriya R, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372:1812–22.

    Article  PubMed  Google Scholar 

  9. Verma A, Mantovan R, Macle L, De Martino G, Chen J, Morillo CA, Novak P, Calzolari V, Guerra PG, Nair G, Torrecilla EG, Khaykin Y. Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial. Eur Heart J. 2010;31:1344–56.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Yu HT, Shim J, Park J, Kim IS, Kim TH, Uhm JS, Joung B, Lee MH, Kim YH, Pak HN. Pulmonary Vein Isolation Alone Versus Additional Linear Ablation in Patients With Persistent Atrial Fibrillation Converted to Paroxysmal Type With Antiarrhythmic Drug Therapy: A Multicenter, Prospective. Randomized Study Circ Arrhythm Electrophysiol. 2017;10:325–32.

    Google Scholar 

  11. Lee JM, Shim J, Park J, Yu HT, Kim TH, Park JK, Uhm JS, Kim JB, Joung B, Lee MH, et al. The electrical isolation of the left atrial posterior wall in catheter ablation of persistent atrial fibrillation. JACC Clinical Electrophysiology. 2019;5:1253–61.

    Article  PubMed  Google Scholar 

  12. Sau A, Howard JP, Al-Aidarous S, Ferreira-Martins J, Al-Khayatt B, Lim PB, Kanagaratnam P, Whinnett ZI, Peters NS, Sikkel MB, Francis DP, Sohaib SMA. Meta-analysis of randomized controlled trials of atrial fibrillation ablation with pulmonary vein isolation versus without. JACC Clin Electrophysiol. 2019;5:968–76.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Zhang Z, Letsas KP, Zhang N, Efremidis M, Xu G, Li G, Liu T. Linear ablation following pulmonary vein isolation in patients with atrial fibrillation: a meta-analysis. Pacing Clin Electrophysiol. 2016;39:623–30.

    Article  PubMed  Google Scholar 

  14. Scott PA, Silberbauer J, Murgatroyd FD. The impact of adjunctive complex fractionated atrial electrogram ablation and linear lesions on outcomes in persistent atrial fibrillation: a meta-analysis. Europace. 2016;18:359–67.

    Article  PubMed  Google Scholar 

  15. Thiyagarajah A, Kadhim K, Lau DH, Emami M, Linz D, Khokhar K, Munawar DA, Mishima R, Malik V, O’Shea C, Mahajan R, Sanders P. Feasibility, safety, and efficacy of posterior wall isolation during atrial fibrillation ablation: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2019;12: e007005.

    Article  PubMed  Google Scholar 

  16. Li F, Tu X, Li D, Jiang Y, Cheng Y, Jia Y, Zhang X, Fu H, Hu H, Jiang J, Zeng R. Is ablation to atrial fibrillation termination of persistent atrial fibrillation the end point?: A systematic review and meta-analysis. Medicine (Baltimore). 2019;98: e18045.

    Article  PubMed  Google Scholar 

  17. Propadalo I, Tranfic M, Vuka I, Barcot O, Pericic TP, Puljak L. In Cochrane reviews, risk of bias assessments for allocation concealment were frequently not in line with Cochrane’s Handbook guidance. J Clin Epidemiol. 2019;106:10–7.

    Article  PubMed  Google Scholar 

  18. Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Lopes RD, Hong H, Harskamp RE, Bhatt DL, Mehran R, Cannon CP, Granger CB, Verheugt FWA, Li J, Ten Berg JM, Sarafoff N, Gibson CM, Alexander JH. Safety and efficacy of antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: a network meta-analysis of randomized controlled trials. JAMA Cardiol. 2019;4:747–55.

    Article  PubMed  PubMed Central  Google Scholar 

  20. van Valkenhoef G, Lu G, de Brock B, Hillege H, Ades AE, Welton NJ. Automating network meta-analysis. Res Synth. Methods. 2012;3:285–99.

    Google Scholar 

  21. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25:3443–57.

    Article  PubMed  Google Scholar 

  22. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.

    Article  CAS  PubMed  Google Scholar 

  23. Mikhaylov E, Gureev S, Szili-Torok T, Lebedev D. Additional left atrial septal line does not improve outcome of patients undergoing ablation for long-standing persistent atrial fibrillation. Acta Cardiol. 2010;65:153–60.

    Article  PubMed  Google Scholar 

  24. Bassiouny M, Saliba W, Hussein A, Rickard J, Diab M, Aman W, Dresing T, Callahan T, Bhargava M, Martin DO, et al. Randomized study of persistent atrial fibrillation ablation: ablate in sinus rhythm versus ablate complex-fractionated atrial electrograms in atrial fibrillation. Circ Arrhythm Electrophysiol. 2016;9: e003596.

    Article  PubMed  Google Scholar 

  25. Mantovan R, Macle L, De Martino G, Chen J, Morillo CA, Novak P, Calzolari V, Khaykin Y, Guerra PG, Nair G, Torrecilla EG, Verma A. Relationship of quality of life with procedural success of atrial fibrillation (AF) ablation and postablation AF burden: substudy of the STAR AF randomized trial. Can J Cardiol. 2013;29:1211–7.

    Article  PubMed  Google Scholar 

  26. Kochhauser S, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan R, Macle L, Morillo CA, Haverkamp W, Weerasooriya R, Albenque JP, Nardi S, Menardi E, Novak P, Sanders P, Verma A, Investigators SAI. Impact of acute atrial fibrillation termination and prolongation of atrial fibrillation cycle length on the outcome of ablation of persistent atrial fibrillation: a substudy of the STAR AF II trial. Heart Rhythm. 2017;14:476–83.

    Article  PubMed  Google Scholar 

  27. Han SW, Shin SY, Im SI, Na JO, Choi CU, Kim SH, Kim JW, Kim EJ, Rha SW, Park CG, Seo HS, Oh DJ, Hwang C, Lim HE. Does the amount of atrial mass reduction improve clinical outcomes after radiofrequency catheter ablation for long-standing persistent atrial fibrillation? Comparison between linear ablation and defragmentation. Int J Cardiol. 2014;171:37–43.

    Article  PubMed  Google Scholar 

  28. Pappone C, Ciconte G, Vicedomini G, Mangual JO, Li W, Conti M, Giannelli L, Lipartiti F, McSpadden L, Ryu K, et al. Clinical outcome of electrophysiologically guided ablation for nonparoxysmal atrial fibrillation using a novel real-time 3-dimensional mapping technique: results from a prospective randomized trial. Circ Arrhythm Electrophysiol. 2018;11: e005904.

    Article  PubMed  Google Scholar 

  29. Calò L, Lamberti F, Loricchio ML, De Ruvo E, Colivicchi F, Bianconi L, Pandozi C, Santini M. Left atrial ablation versus biatrial ablation for persistent and permanent atrial fibrillation. a prospective and randomized study. Journal of the American College of Cardiology. 2006;47:2504–12.

    Article  PubMed  Google Scholar 

  30. Elayi CS, L DIB, Bai R, Burkhardt JD, Mohanty P, Sanchez J, Santangeli P, Hongo R, Gallinghouse GJ, Horton R, Bailey S, Zagrodzky J, Beheiry S and Natale A. Identifying the relationship between the non-PV triggers and the critical CFAE sites post-PVAI to curtail the extent of atrial ablation in longstanding persistent AF. J Cardiovasc Electrophysiol. 2011;22:1199–205.

    Article  PubMed  Google Scholar 

  31. Dixit S, Marchlinski FE, Lin D, Callans DJ, Bala R, Riley MP, Garcia FC, Hutchinson MD, Ratcliffe SJ, Cooper JM, Verdino RJ, Patel VV, Zado ES, Cash NR, Killian T, Tomson TT, Gerstenfeld EP. Randomized ablation strategies for the treatment of persistent atrial fibrillation RASTA study. Circulation Arrhythmia and Electrophysiology. 2012;5:287–94.

    Article  PubMed  Google Scholar 

  32. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL. Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:4194.

    Article  PubMed  Google Scholar 

  33. Di Biase L, Burkhardt JD, Mohanty P, Mohanty S, Sanchez JE, Trivedi C, Güneş M, Gökoğlan Y, Gianni C, Horton RP, Themistoclakis S, Gallinghouse GJ, Bailey S, Zagrodzky JD, Hongo RH, Beheiry S, Santangeli P, Casella M, Dello Russo A, Al-Ahmad A, Hranitzky P, Lakkireddy D, Tondo C, Natale A. Left atrial appendage isolation in patients with longstanding persistent AF undergoing catheter ablation: BELIEF Trial. J Am Coll Cardiol. 2016;68:1929–40.

    Article  PubMed  Google Scholar 

  34. Lee JM, Shim J, Park J, Yu HT, Kim TH, Park JK, Uhm JS, Kim JB, Joung B, Lee MH, Kim YH, Pak HN. The electrical isolation of the left atrial posterior wall in catheter ablation of persistent atrial fibrillation. JACC Clinical Electrophysiology. 2019;5:1253–61.

    Article  PubMed  Google Scholar 

  35. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG. American College of C, American Heart A, European Society of C, North American Society of P and Electrophysiology. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J. 2001;22:1852–923.

    Article  CAS  PubMed  Google Scholar 

  36. Pak HN, Park J, Park JW, Yang SY, Yu HT, Kim TH, Uhm JS, Choi JI, Joung B, Lee MH, Kim YH, Shim J. Electrical Posterior Box Isolation in Persistent Atrial Fibrillation Changed to Paroxysmal Atrial Fibrillation: A Multicenter, Prospective. Randomized Study Circ Arrhythm Electrophysiol. 2020;13:e008531.

  37. Willems S, Klemm H, Rostock T, Brandstrup B, Ventura R, Steven D, Risius T, Lutomsky B, Meinertz T. Substrate modification combined with pulmonary vein isolation improves outcome of catheter ablation in patients with persistent atrial fibrillation: a prospective randomized comparison. Eur Heart J. 2006;27:2871–8.

    Article  PubMed  Google Scholar 

  38. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ, Jr., Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D, Heart Rhythm Society Task Force on C and Surgical Ablation of Atrial F. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm. 2012;9(632–696):e621.

    Google Scholar 

  39. Pokushalov E, Romanov A, Katritsis DG, Artyomenko S, Shirokova N, Karaskov A, Mittal S, Steinberg JS. Ganglionated plexus ablation vs linear ablation in patients undergoing pulmonary vein isolation for persistent/long-standing persistent atrial fibrillation: a randomized comparison. Heart Rhythm. 2013;10:1280–6.

    Article  PubMed  Google Scholar 

  40. Wang YL, Liu X, Tan HW, Zhou L, Jiang WF, Gu J, Liu YG. Evaluation of linear lesions in the left and right atrium in ablation of long-standing atrial fibrillation. PACE - Pacing and Clinical Electrophysiology. 2013;36:1202–10.

    PubMed  Google Scholar 

  41. Mamchur SE, Mamchur IN, Khomenko EA, Bokhan NS, Scherbinina DA. “Electrical exclusion” of a critical myocardial mass by extended pulmonary vein antrum isolation for persistent atrial fibrillation treatment. Interventional Medicine and Applied Science. 2014;6:31–9.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Wang XH, Li Z, Mao JL, He B. A novel individualized substrate modification approach for the treatment of long-standing persistent atrial fibrillation: preliminary results. Int J Cardiol. 2014;175:162–8.

    Article  PubMed  Google Scholar 

  43. Atienza F, Almendral J, Ormaetxe JM, Moya A, Martínez-Alday JD, Hernández-Madrid A, Castellanos E, Arribas F, Arias MA, Tercedor L, Peinado R, Fe Arcocha M, Ortiz M, Martínez-Alzamora N, Arenal A, Fernández-Avilés F, Jalife J. Comparison of radiofrequency catheter ablation of drivers and circumferential pulmonary vein isolation in atrial fibrillation: A noninferiority randomized multicenter RADAR-AF trial. J Am Coll Cardiol. 2014;64:2455–67.

    Article  PubMed  Google Scholar 

  44. Dong JZ, Sang CH, Yu RH, Long DY, Tang RB, Jiang CX, Ning M, Liu N, Liu XP, Du X, Tse HF, Ma CS. Prospective randomized comparison between a fixed “2C3L” approach vs. stepwise approach for catheter ablation of persistent atrial fibrillation. Europace. 2015;17:1798–806.

    Article  PubMed  Google Scholar 

  45. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Huezey JY, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol. 2011;57:e101-198.

    Article  PubMed  Google Scholar 

  46. Wong KCK, Paisey JR, Sopher M, Balasubramaniam R, Jones M, Qureshi N, Hayes CR, Ginks MR, Rajappan K, Bashir Y, Betts TR. No Benefit of complex fractionated atrial electrogram ablation in addition to circumferential pulmonary vein ablation and linear ablation: benefit of complex ablation study. Circulation: Arrhythmia and Electrophysiology. 2015;8:1316–24.

    PubMed  Google Scholar 

  47. Zhang J, Tang C, Zhang Y, Su XI. Electrophysiologic and clinical consequences of left atrial anterior wall linear ablation in patients with persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2015;26:934–43.

    Article  PubMed  Google Scholar 

  48. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, American College of C, American Heart Association Task F, European Society of Cardiology Committee for Practice G, European Heart Rhythm A and Heart Rhythm S. ACC/AHA/ESC. guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006;2006(8):651–745.

    Google Scholar 

  49. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, American College of Cardiology/American Heart Association Task Force on Practice G, European Society of Cardiology Committee for Practice G, European Heart Rhythm A and Heart Rhythm S. ACC/AHA/ESC. Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;2006(114):e257-354.

    Google Scholar 

  50. Fink T, Schlüter M, Heeger CH, Lemes C, Maurer T, Reissmann B, Riedl J, Rottner L, Santoro F, Schmidt B, Wohlmuth P, Mathew S, Sohns C, Ouyang F, Metzner A and Kuck KH. Stand-alone pulmonary vein isolation versus pulmonary vein isolation with additional substrate modification as index ablation procedures in patients with persistent and long-standing persistent atrial fibrillation: the randomized Alster-Lost-AF Trial (Ablation at St. Georg Hospital for Long-Standing Persistent Atrial Fibrillation). Circulation: Arrhythmia and Electrophysiology 2017;10(7):e005114. https://doi.org/10.1161/CIRCEP.117.005114.

  51. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC Jr, Klein WW, Alonso-Garcia A, Blomstrom-Lundqvist C, de Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A. American College of Cardiology/American Heart Association Task Force on Practice G, European Society of Cardiology Committee for Practice G, Policy C, North American Society of P and Electrophysiology. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation. 2001;104:2118–50.

    Article  CAS  PubMed  Google Scholar 

  52. Yu HT, Shim J, Park J, Kim IS, Kim TH, Uhm JS, Joung B, Lee MH, Kim YH and Pak HN. Pulmonary vein isolation alone versus additional linear ablation in patients with persistent atrial fibrillation converted to paroxysmal type with antiarrhythmic drug therapy: a multicenter, prospective, randomized study. Circulation: Arrhythmia and Electrophysiology 2017;10(6):e004915.

  53. Yang B, Jiang C, Lin Y, Yang G, Chu H, Cai H, Lu F, Zhan X, Xu J, Wang X, Ching CK, Singh B, Kim YH, Chen M and Investigators* S-S. STABLE-SR (Electrophysiological Substrate Ablation in the Left Atrium During Sinus Rhythm) for the treatment of nonparoxysmal atrial fibrillation: a prospective, multicenter randomized clinical trial. Circ Arrhythm Electrophysiol 2017;10(11):e005405.

  54. Mohanty S, Gianni C, Trivedi C, Metz T, Bai R, Al-Ahmad A, Bailey S, Burkhardt JD, Gallinghouse GJ, Horton R, Hranitzky PM, Sanchez JE, Di Biase L, Natale A. Impact of rotor ablation in non-paroxysmal AF patients: findings from the per-protocol population of the OASIS trial at long-term follow-up. Am Heart J. 2018;205:145–8.

    Article  PubMed  Google Scholar 

  55. Lin R, Zeng C, Xu K, Wu S, Qin M, Liu X. Dispersion-guided ablation in conjunction with circumferential pulmonary vein isolation is superior to stepwise ablation approach for persistent atrial fibrillation. Int J Cardiol. 2019;278:97–103.

    Article  PubMed  Google Scholar 

  56. Yamaji H, Murakami T, Hina K, Higashiya S, Kawamura H, Murakami M, Kamikawa S, Hirohata S, Kusachi S. Adjunctive left anterior line ablation induced left atrial dysfunction and dyssynchrony in atrial fibrillation ablation. Heart Vessels. 2019;34:331–42.

    Article  PubMed  Google Scholar 

  57. Yao Y, Hu F, Du Z, He J, Shi H, Zhang J, Cai H, Jia Y, Tang M, Niu G, et al. The value of extensive catheter linear ablation on persistent atrial fibrillation (the CLEAR-AF Study). International journal of cardiology. 2020;316:125–9.

    Article  PubMed  Google Scholar 

  58. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659–66.

    Article  CAS  PubMed  Google Scholar 

  59. Seitz J, Horvilleur J, Curel L, Lacotte J, Maluski A, Ferracci A, Bremondy M, Rosier A, Monchi M, Penaranda G, Faure J, Beurtheret S, Pisapia A. Active or passive pulmonary vein in atrial fibrillation: is pulmonary vein isolation always essential? Heart Rhythm. 2014;11:579–86.

    Article  PubMed  Google Scholar 

  60. Lapenna E, De Bonis M, Giambuzzi I, Del Forno B, Ruggeri S, Cireddu M, Gulletta S, Castiglioni A, Alfieri O, Della Bella P, Benussi S. Long-term outcomes of stand-alone maze IV for persistent or long-standing persistent atrial fibrillation. Ann Thorac Surg. 2020;109:124–31.

    Article  PubMed  Google Scholar 

  61. Vogler J, Willems S, Sultan A, Schreiber D, Lüker J, Servatius H, Schäffer B, Moser J, Hoffmann BA, Steven D. Pulmonary vein isolation versus defragmentation. The CHASE-AF Clinical Trial. Journal of the American College of Cardiology. 2015;66:2743–52.

    Article  PubMed  Google Scholar 

  62. Bisbal F, Mont L. (2014) New insights on ablation of persistent atrial fibrillation: evidence from the sara trial. J Atr Fibrillation. 2014;7(2):1114.

    PubMed Central  Google Scholar 

  63. Sawhney N, Anousheh R, Chen W, Feld GK. Circumferential pulmonary vein ablation with additional linear ablation results in an increased incidence of left atrial flutter compared with segmental pulmonary vein isolation as an initial approach to ablation of paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3:243–8.

    Article  PubMed  Google Scholar 

  64. Shah AJ, Jadidi A, Liu X, Miyazaki S, Forclaz A, Nault I, Rivard L, Linton N, Xhaet O, Derval N, Sacher F, Bordachar P, Ritter P, Hocini M, Jais P, Haissaguerre M. Atrial tachycardias arising from ablation of atrial fibrillation: a proarrhythmic bump or an antiarrhythmic turn? Cardiol Res Pract. 2010;2010: 950763.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Shah AJ, Pascale P, Miyazaki S, Liu X, Roten L, Derval N, Jadidi AS, Scherr D, Wilton SB, Pedersen M, Knecht S, Sacher F, Jais P, Haissaguerre M, Hocini M. Prevalence and types of pitfall in the assessment of mitral isthmus linear conduction block. Circ Arrhythm Electrophysiol. 2012;5:957–67.

    Article  PubMed  Google Scholar 

  66. Oral H, Chugh A, Yoshida K, Sarrazin JF, Kuhne M, Crawford T, Chalfoun N, Wells D, Boonyapisit W, Veerareddy S, et al. A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation. J Am Coll Cardiol. 2009;53:782–9.

    Article  PubMed  Google Scholar 

  67. Tokioka S, Fukamizu S, Kimura T, Takahashi M. Kitamura T and Hojo R (2021) The effect of posterior wall isolation for persistent atrial fibrillation on recurrent arrhythmia. J Cardiovasc Electrophysiol. 2021;32(3):597–604.

  68. Bai R, Di Biase L, Mohanty P, Trivedi C, Dello Russo A, Themistoclakis S, Casella M, Santarelli P, Fassini G, Santangeli P, Mohanty S, Rossillo A, Pelargonio G, Horton R, Sanchez J, Gallinghouse J, Burkhardt JD, Ma CS, Tondo C, Natale A. Proven isolation of the pulmonary vein antrum with or without left atrial posterior wall isolation in patients with persistent atrial fibrillation. Heart Rhythm. 2016;13:132–40.

    Article  PubMed  Google Scholar 

  69. Suenari K, Chen YC, Kao YH, Cheng CC, Lin YK, Chen YJ, Chen SA. Discrepant electrophysiological characteristics and calcium homeostasis of left atrial anterior and posterior myocytes. Basic Res Cardiol. 2011;106:65–74.

    Article  CAS  PubMed  Google Scholar 

  70. Rohr S. Arrhythmogenic implications of fibroblast-myocyte interactions. Circ Arrhythm Electrophysiol. 2012;5:442–52.

    Article  PubMed  Google Scholar 

  71. Narayan SM, Krummen DE, Shivkumar K, Clopton P, Rappel WJ, Miller JM. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol. 2012;60:628–36.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Briceno DF, Patel K, Romero J, Alviz I, Tarantino N, Della Rocca DG, Natale V, Zhang XD, Di Biase L. Beyond pulmonary vein isolation in nonparoxysmal atrial fibrillation: posterior wall, vein of Marshall, coronary sinus, superior vena cava, and left atrial appendage. Card Electrophysiol Clin. 2020;12:219–31.

    Article  PubMed  Google Scholar 

  73. Takamiya T, Nitta J, Sato A, Inamura Y, Kato N, Inaba O, Negi K, Yamato T, Matsumura Y, Takahashi Y, Goya M, Hirao K. Pulmonary vein isolation plus left atrial posterior wall isolation and additional nonpulmonary vein trigger ablation using high-dose isoproterenol for long-standing persistent atrial fibrillation. J Arrhythm. 2019;35:215–22.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Conti S, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan R, Macle L, Morillo CA, Haverkamp W, Weerasooriya R, et al. Effect of different cutpoints for defining success post-catheter ablation for persistent atrial fibrillation: a substudy of the STAR AF II trial. JACC Clinical electrophysiology. 2017;3:522–3.

    Article  PubMed  Google Scholar 

  75. Jadidi AS, Duncan E, Miyazaki S, Lellouche N, Shah AJ, Forclaz A, Nault I, Wright M, Rivard L, Liu X, Scherr D, Wilton SB, Sacher F, Derval N, Knecht S, Kim SJ, Hocini M, Narayan S, Haissaguerre M, Jais P. Functional nature of electrogram fractionation demonstrated by left atrial high-density mapping. Circ Arrhythm Electrophysiol. 2012;5:32–42.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was sponsored by the Natural Science Foundation of Shandong Province of China [ZR2019PH036] and the Key Research and Development Plan of Jinan Shandong Province of China [201805056].

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shaolei Yi.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Sijia Wu, Hongkai Li, and Shaolei Yi are co-first authors.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 3054 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, S., Li, H., Yi, S. et al. Comparing the efficacy of catheter ablation strategies for persistent atrial fibrillation: a Bayesian analysis of randomized controlled trials. J Interv Card Electrophysiol 66, 757–770 (2023). https://doi.org/10.1007/s10840-022-01246-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-022-01246-5

Keywords

Navigation